Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Combined with Chemoradiotherapy for the Treatment of Unresectable Locally Advanced Non-small Cell Lung Cancer

Growth Factor ◽

Kinase Inhibitor ◽

Locally Advanced ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?

The Korean Journal of Internal Medicine ◽

10.3904/kjim.2016.190 ◽

2017 ◽

Vol 32 (3) ◽

pp. 422-428 ◽

Cited By ~ 1

Author(s):

Yong Won Choi ◽

Jin-Hyuk Choi

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Egfr Mutation ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Valuable lessons from treatment of non-small cell lung cancer with erlotinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor

BMJ Case Reports ◽

10.1136/bcr.06.2008.0075 ◽

2008 ◽

Vol 2008 (nov12 1) ◽

pp. bcr0620080075-bcr0620080075 ◽

Cited By ~ 1

Author(s):

R. K Shrimali ◽

P. D Correa ◽

M. Rizwanullah

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Abstract 1467: BLU-945, a fourth-generation, potent and highly selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with intracranial activity, demonstrates robustin vivoantitumor activity in models of osimertinib-resistant non-small cell lung cancer (NSCLC)

10.1158/1538-7445.am2021-1467 ◽

2021 ◽

Author(s):

Sun Min Lim ◽

Chae Won Park ◽

Zhuo Zhang ◽

Rich Woessner ◽

Tom Dineen ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Fourth Generation ◽

Small Cell Lung ◽

Combined epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor and chemotherapy in non-small-cell lung cancer: Chemo-refractoriness of cells harboring sensitizing-EGFR mutations in the presence of gefitinib

Lung Cancer ◽

10.1016/j.lungcan.2013.08.028 ◽

2013 ◽

Vol 82 (2) ◽

pp. 305-312 ◽

Cited By ~ 15

Author(s):

Chun-Ming Tsai ◽

Jen-Ting Chen ◽

Chao-Hua Chiu ◽

Chun-Liang Lai ◽

Shih-Yin Hsiao ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

P3-143: Disease control with a second Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitor (TKI) after failure of a first TKI in Asian patients with non-small cell lung cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000284118.51207.67 ◽

2007 ◽

Vol 2 (8) ◽

pp. S740

Author(s):

Ross Soo ◽

Alvin Wong ◽

Siew-Woon Lim ◽

Tan-Min Chin ◽

Richie Soong

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Asian Patients ◽

211P First analysis of a real-world study to explore the character and treatment outcome of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) on non-small cell lung cancer (NSCLC) with brain metastases (BM)

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(18)30484-2 ◽

2018 ◽

Vol 13 (4) ◽

pp. S126

Author(s):

H. Zhang ◽

L. Liu ◽

C. Zhang ◽

N. Zhang ◽

H. Su ◽

...

Keyword(s):

Lung Cancer ◽

Treatment Outcome ◽

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Objective regressions in non-small cell lung cancer patients treated in Phase I trials of oral ZD1839 (IressaTM), a selective tyrosine kinase inhibitor that blocks the epidermal growth factor receptor (EGFR)

Lung Cancer ◽

10.1016/s0169-5002(00)80233-0 ◽

2000 ◽

Vol 29 (1) ◽

pp. 72 ◽

Cited By ~ 34

Author(s):

M.G Kris ◽

R Herbst ◽

D Rischin ◽

P LoRusso ◽

J Baselga ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Phase I Trials ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Targeting Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer by Inducing Epidermal Growth Factor Receptor DegradationviaMethionine 790 Oxidation

Antioxidants and Redox Signaling ◽

10.1089/ars.2015.6420 ◽

2016 ◽

Vol 24 (5) ◽

pp. 263-279 ◽

Cited By ~ 39

Author(s):

Elaine Lai-Han Leung ◽

Xing-Xing Fan ◽

Maria Pik Wong ◽

Zhi-Hong Jiang ◽

Zhong-Qiu Liu ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

125P Association of tumour CD4 positive lymphocytes with prognosis in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor

Annals of Oncology ◽

10.1016/j.annonc.2020.08.246 ◽

2020 ◽

Vol 31 ◽

pp. S290

Author(s):

Y-J. Zhu ◽

H-B. Zhang ◽

X-S. Chang ◽

Z-Z. Xiao ◽

L-R. Liu ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

A Comparative Study of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Treatment of Patients with Brain Metastasis from Non-Small Cell Lung Cancer

Annals of Oncology ◽

10.1016/s0923-7534(20)33879-5 ◽

2012 ◽

Vol 23 ◽

pp. ix421

Author(s):

L. Zhang ◽

L. Cai ◽

J. Zhu

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Brain Metastasis ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽